NCIMMUNE LEADING EARLY CANCER DETECTION

To view the current EarlyCDT-Lung test providers, please select the geographic region of your choice by clicking on the relevant button above.

If you are interested in becoming a provider of EarlyCDT-Lung please complete the form or contact us at contact@oncimmune.co.uk or +44 (0)115 8231869.

If you are a Consultant and would like to be included in this list, or for more information, then please contact enquiries@oncimmune.co.uk.

There are multiple healthcare providers currently offering the EarlyCDTLung test in the US.

Please contact clientservices@oncimmune.com or call 1-888-583-9030 for more details.

If you are interested in becoming a provider of EarlyCDTLung please contact us at clientservices@oncimmune.com or 1-888-583-9030, or complete the enquiry form.

The following healthcare providers are currently offering the EarlyCDTLung test in Asia.

For any enquiries regarding the following information, please email
enquiries@oncimmune.co.uk.

AceCGT Diagnostic Limited – Hong Kong
AceCGT Diagnostic Limited is a leading clinical diagnostic laboratory specializing in molecular diagnosis and early cancer detection. They strongly believe that screening and diagnostic tests are the foundation of a successful health care system by providing critical information for both health care providers and patients to make the right medical decisions. AceCGT Diagnostic is committed to improving overall patient care by delivering and developing innovative, affordable, and widely-accessible testing services through the network.

AceCGT Diagnostic believes in the goal of EarlyCDTLung blood test – to detect lung cancer early and save lives.

Please visit: http://www.acecgtdiagnostic.com/LungCDT/index.html for more information, or telephone +(852) 3979 3200.

Best Med Opinion Ltd. – Israel
Best Med Opinion Ltd is a leading provider of second opinions, clinical services and advanced medical diagnostics in Israel and several other countries, working with insurance companies, large organizations and private patients.

Best Med Opinion Ltd. has developed a network of specialty providers in the U.S. and other countries to assist physicians and patients in ensuring all clinical options are known and explored before a particular course of treatment is selected.

For further information on Best Med Opinion Ltd. and the EarlyCDT-Lung test, please email eran@best-med-opinion.com or call 03-5117157.

Dow Biomedica – Korea
Dow Biomedica

Invision Biotech – Taiwan
Invision Biotech

If you are interested in becoming a provider of EarlyCDTLung please complete the form or contact us at contact@oncimmune.co.uk or +44 (0)115 8231869.

The following healthcare providers are currently offering the EarlyCDTLung test in the UK.

Please note that in the UK the test is only available privately from these providers. You may need a letter of referral from your GP. For any enquiries regarding the following information, please email enquiries@oncimmune.co.uk.

 

The Doctors Laboratory (TDL) is a medically-led laboratory and the largest independent provider of diagnostic pathology services in the UK. TDL’s laboratories are CPA accredited in all disciplines. TDL is  now offering the EarlyCDT-Lung test. Please visit http://www.tdlpathology.com/ for more information about TDL.

Information for PATIENTS:
The EarlyCDT-Lung test needs to be requested through your GP or your Specialist/Consultant. Your doctor may recommend an EarlyCDT-Lung test as a helpful, or important, test for you, or you may want to request this test with their help. To arrange the EarlyCDT-Lung test, it is therefore important that you visit your GP for a letter of referral, or  a request form, for you. If you would like a pathology postal pack to be sent to your address you can then take this pack to your GP for them, or their nurse, to take your sample. Alternatively you may take your pack to a local private hospital or clinic for sample taking. Please ensure that your doctor’s request form or letter is enclosed with your sample before posting it back to the laboratory. Results will be sent to your GP or Consultant within 7-9 days.
If you would like to order a pathology pack please telephone 0207 307 7343 or email earlyCDTLung@tdlpathology.com.
Information for GPs/CONSULTANTS:
Please contact TDL (http://www.tdlpathology.com/) on 0207 307 7343 or by email to earlyCDTLung@tdlpathology.com for information about taking and sending samples for EarlyCDT-Lung. TDL will provide you with postal packs or advise on local sample taking, or  courier collection arrangements, as needed.  Please ensure that your letter of referral, or your completed request form, is enclosed with the sample, confirming your details.

For information, or to order pathology packs, please telephone 0207 307 7343 or email earlyCDTLung@tdlpathology.com.

LungHealth UK (part of Check4Cancer Ltd.) is the leading provider of early detection of lung cancer services and combines the experience of leading clinical specialists with the latest approaches and techniques.Available throughout a network of over 75 clinics across the United Kingdom and internationally, LungHeath UK services are designed to detect lung cancer at an early stage allowing greater opportunity for successful treatment.LungCheck, based on the unique blood test (EarlyCDT-Lung), is suitable for men and women, current and past heavy smokers over the age of 40. You can find out your symptomatic score by completing the survey here.If patients have a moderate or high EarlyCDT-Lung test result, they will be offered a follow up CT scan, free of charge.Privacy and confidentiality is ensured throughout the process and LungHealth UK is regulated by the Care Quality Commission.For information and to book an appointment, please visit the LungHealth UK website.

If you are interested in becoming a provider of EarlyCDTLung please complete the form or contact us at contact@oncimmune.co.uk or +44 (0)115 8231869.

Consultant Referrals:

The following Consultants, available for private referrals, know specifically about this test and are familiar with recommended follow-up procedures. Please feel free to use other Consultants as you see fit:

  • Prof Sam Janes, Professsor of Respiratory Medicine. (020 7034 8164). Professor Janes is a Consultant in Respiratory Medicine at University College London Hospitals NHS Foundation Trust and the lead clinician for lung cancer across North Central and North East London. He is active in research and is lead investigator on several lung trials.
  • Dr Pallav Shah, Consultant Physician in Respiratory Medicine. (020 7351 8021). Dr Shah is the Lead Clinician for lung cancer services at Royal Brompton Hospital and the Chelsea & Westminster Hospital, as well as Honorary Consultant Physician to the Royal Marsden Hospital and the Royal Hospital Chelsea, London.

If you are a Consultant and would like to be included in this list, or for more information, then please contact enquiries@oncimmune.co.uk.

The following healthcare providers are currently offering the EarlyCDTLung test in Europe (non-UK).

For any enquiries regarding the following information, please email
enquiries@oncimmune.co.uk.

XboXLab – Sweden
XboXLab is a new company within the laboratory and diagnostics industry and is built on solid knowledge and broad experience. With 75 years of experience in this business, we currently have a large network of customers in Sweden and the Nordic countries. Our aim is to offer innovative products and provide our customers and suppliers a Flexible, Personal and Professional service.

XboXLab AB, Svampgatan 2, 573 43 Tranås, Sweden. info@xboxlab.se

LABLAB ApS – Denmark
LABLAB ApS is a Danish distribution company within Diagnostics and Research.

LABLAB offer innovative products, quality and good service, and supply instruments, assays and reagents for a large variety of applications in routine and research.

LABLAB ApS, Oehlenschlægersvej 22, 5230 Odense M. Denmark info@lablab.dk

DiuVita Diagnostics – Norway
DiuVita Diagnostics AS is a company within the laboratory and diagnostic industry. The company was founded April 1st 2015 and has 5 shareholders. Our focus is autoimmunity, clinical chemistry, diagnostic controls, blood-bank, molecular biology, microbiology & HLA. DiuVita is built on a solid knowledge and broad experience from many years of laboratory, sales, and professional medical support. We have a large network of customers in Norway and Iceland.

DiuVita means LONG LIFE, and we want to take care of our customers with the best personal and professional service and products.
“We care for the environment and You.”

DiuVita Diagnostics AS, Bukken Bruse 8, 3055 Krokstadelva, Norway. post@diuvita.no

If you are interested in becoming a provider of EarlyCDTLung please complete the form or contact us at contact@oncimmune.co.uk or +44 (0)115 8231869.

PLEASE READ THE FOLLOWING STATEMENT CAREFULLY

Electronic versions of the materials you are seeking to access are being made available on this website by Oncimmune Holdings plc (the “Company”).

These materials are not directed to nor are they intended for access by persons located or resident in the United States, Australia, Canada, South Africa, Japan or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.

None of the securities of Company discussed or referred to in the materials you are seeking to access have been registered under the US Securities Act or 1933, as amended (the “Securities Act”) and may not be offered, sold, pledged or otherwise transferred except (1) in an offshore transaction meeting the requirements of Rule 903 or Rule 904 of Regulation S under the Securities Act, (2) pursuant to an effective registration statement under the Securities Act, or (3) pursuant to an available exemption from the registration requirements of the Securities Act, in each case in accordance with all applicable securities laws.

By clicking the “SUBMIT” button below you confirm that you (1) have read and understood the information set out above, (2) agree to be bound by its terms, (3) are not located in the United States and do not have a registered address in, and are not resident or located in, Australia, Canada, South Africa or Japan and (4) are permitted under applicable law and regulation to proceed to the following parts of this website.

Please click on the button below to confirm that you have read, understood and agree with the disclaimer above.

Yes, I accept No, I don't accept